Showing results (711-720 of 16,804) with videos related to
Sort By:
Pageof 1,681
British Journal of Haematology|September 27, 2003
The type 1 CD10/neutral endopeptidase 24.11 promoter: functional characterization of the 5'-untranslated regionNobuo Sezaki, Fumihiko Ishimaru, Takayuki Tabayashi, et al.British Journal of Haematology|February 12, 2004
Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasiaGiovanni Barosi, Vittorio Rosti, Margherita Massa, et al.British Journal of Haematology|February 12, 2004
Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assaysA H C Guimarães, N H van Tilburg, H L Vos, et al.British Journal of Haematology|February 12, 2004
Human haematopoietic stem cells that mediate long-term in vivo engraftment are not susceptible to infection by human cytomegalovirusKirsten B Crapnell, Graca Almeida-Porada, Svetlana Khaiboullina, et al.British Journal of Haematology|May 8, 2013
A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignanciesGert J Ossenkoppele, Bob Lowenberg, Pierre Zachee, et al.British Journal of Haematology|April 18, 2013
SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617FMaya Koren-Michowitz, Sigal Gery, Takayuki Tabayashi, et al.British Journal of Haematology|March 19, 2013
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioningWilliam M Townsend, Ailsa Holroyd, Rachel Pearce, et al.British Journal of Haematology|February 26, 2013
The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosisShira Dinner, Wesley Witteles, Ronald Witteles, et al.British Journal of Haematology|May 25, 2013
Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosisDaniel J DeAngelo, Ruben A Mesa, Warren Fiskus, et al.British Journal of Haematology|May 30, 2013
The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United KingdomInês Zimbarra Cabrita, Abubakar Mohammed, Mark Layton, et al.Pageof 1,681